泰兰加纳推出了印度第一个单一用途生物加工设施,以促进生物技术创新、降低成本和吸引投资。 Telangana launched India’s first single-use bioprocess facility to boost biotech innovation, cutting costs and attracting investment.

泰兰加纳(Telangana)在海得拉巴的基因组谷地启动了印度第一个单一用途生物工艺设计和扩大设施(1 Bio), 提升了印度的生物制药能力。 Telangana has launched India’s first single-use bioprocess design and scale-up facility, 1 Bio, in Hyderabad’s Genome Valley, advancing the nation’s biopharmaceutical capabilities. 这座占地2英的校园由州政府,生物技术部和Thermo Fisher Scientific公司支持开发, 占地15万平方米. Developed with support from the state government, Department of Biotechnology, and Thermo Fisher Scientific, the 2-acre campus includes 150,000 sq. 研究与发展实验室、最多500升的生物反应器和先进处理系统。 ft. of R&D labs, bioreactors up to 500 liters, and advanced processing systems. 该设施是200卢比基础设施升级的一部分,旨在削减生物技术公司的发展成本和时间,吸引500卢比私人投资,创造500多个就业机会。 The facility, part of a Rs 200 crore infrastructure upgrade, aims to cut development costs and time for biotech firms, attract Rs 500 crore in private investment, and create over 500 jobs. 其开业适逢基因组谷地25周年, 以新标志和网关结构计划为标志。 Its opening coincided with Genome Valley’s 25th anniversary, marked by a new logo and plans for a gateway structure. Thermo Fisher还开设了生物过程设计中心和客户经验中心,支持对细胞和基因疗法、MRNA和肿瘤学的研究,投资总额为85-90卢比。 Thermo Fisher also opened a Bioprocess Design Centre and Customer Experience Centre, supporting research in cell and gene therapy, mRNA, and oncology, with a combined investment of Rs 85–90 crore.